cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Abbott Laboratories
333 own
257 watching
Current Price
$104.26
$0.08
(0.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
194,654.5M
52-Week High
52-Week High
121.64000
52-Week Low
52-Week Low
89.67000
Average Volume
Average Volume
2.73M
Dividend Yield
Dividend Yield
0.014473
P/E Ratio
P/E Ratio
30.7148
iconMarket Capitalization194,654.5M
icon52-Week High121.64000
icon52-Week Low89.67000
iconAverage Volume2.73M
iconDividend Yield0.014473
iconP/E Ratio30.7148
What does the Abbott Laboratories do?
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Read More
How much money does Abbott Laboratories make?
News & Events about Abbott Laboratories.
PR Newswire
1 year ago
Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker PR Newswire ABBOTT PARK, Ill., July 5, 2023 Abbott's breakthrough technology enables the world's first beat-to-beat, wireless communication...
PR Newswire
1 year ago
Abbott Hosts Conference Call for Second-Quarter Earnings Abbott Hosts Conference Call for Second-Quarter Earnings PR Newswire ABBOTT PARK, Ill., June 29, 2023 ABBOTT PARK, Ill., June 29, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2023 financial results on Thursday...
Accesswire
1 year ago
ARLINGTON, VA and ABBOTT PARK, IL / ACCESSWIRE / June 28, 2023 / Abbott:AbbottOn June 24, the American Diabetes Association® (ADA) and Abbott announced a collaboration aimed at better understanding how diabetes technology like continuous glucose monitoring (CGM) systems can help people...
Ticker Report
1 year ago
Valeo Financial Advisors LLC raised its position in shares of Abbott Laboratories (NYSE:ABT Get Rating) by 7.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,396 shares of the healthcare ...
Ticker Report
1 year ago
Hills Bank Trust Co increased its stake in shares of Abbott Laboratories (NYSE:ABT Get Rating) by 1.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The firm owned 43,296 shares of the healthcare product...
Frequently Asked Questions
Frequently Asked Questions
What is Abbott Laboratories share price today?
plus_minus_icon
Can Indians buy Abbott Laboratories shares?
plus_minus_icon
How can I buy Abbott Laboratories shares from India?
plus_minus_icon
Can Fractional shares of Abbott Laboratories be purchased?
plus_minus_icon
What are the documents required to start investing in Abbott Laboratories stocks?
plus_minus_icon
What is today’s traded volume of Abbott Laboratories?
plus_minus_icon
What is today’s market capitalisation of Abbott Laboratories?
plus_minus_icon
What is the 52-Week High and Low Range of Abbott Laboratories?
plus_minus_icon
What percentage is Abbott Laboratories down from its 52-Week High?
plus_minus_icon
What percentage is Abbott Laboratories up from its 52-Week Low?
plus_minus_icon
Current Price
$104.26
$0.08
(0.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00